Our new preprint is out!

A new preprint on how LRRK2 deregulates the most vulnerable dopamine neuron subtypes in Parkinson's disease. I am incredible thrilled about this work, as it reflects the seamless collaboration among various labs, each bringing their unique expertise—just as science should advance.

https://www.biorxiv.org/content/10.1101/2025.08.28.672006v1.full.pdf

LRRK2 in vulnerable dopamine neuron subtypes

Our collaborative paper with our ASAP team is now published in eLIfe.

Another publication from the lab!

"Could LRRK2 Inhibition Be the Key to Reducing Antipsychotic Side Effects?"

Check our new publication in Molecular Psychiatry! https://www.nature.com/articles/s41380-025-03030-z

Our new publication is out in Communications Biology! https://www.nature.com/articles/s42003-022-04136-8

Loukia is in the Bahamas for the ASAP meeting

Please do not disturb! I am in paradise !

Our SpotLIght published in Trends in Biochemical Sciences. Plus, it is authored by three women.

https://www.sciencedirect.com/science/article/pii/S0968000421002243?via%3Dihub#f0005

Our lab receives a multi-million grant to advance PD research

https://parkinsonsroadmap.org/research-network/circuitry/

Excited and honored to be a Core Leadership member in a multi-million funded grant from ASAP. Thrilled to be part of a consortium of exceptional scientists across geographies and disciplines.

Loukia has become a core leadership member in one of the funded ASAP teams

Time for collaboration and teamwork!

Drinks with the lab with an amazing view at lakefront Chicago!

Patrick is reappointed in the Mechanisms of Aging and Dementia T32 grant !

Well done Patrick!